ZACHARY WHITESIDE
SARASOTA, FL NPI 1295358554
Browse related groups: FL Edwards Lifesciences Corporation All categories
General Payments — all program years on this page
$991.83
- Category: General Payments
- Program years: PY2023–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $596.95 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $596.95 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Edwards Lifesciences Corporation | $194.31 | 2 |
| Abbott Laboratories | $161.91 | 1 |
| ShockWave Medical, Inc | $103.27 | 1 |
| Medtronic, Inc. | $41.42 | 1 |
| Acerta Pharma LLC | $40.99 | 1 |
| ABIOMED | $31.45 | 1 |
| Actelion Pharmaceuticals US, Inc. | $23.60 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078879330 | Actelion Pharmaceuticals US, Inc. | $23.60 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110511714 | AstraZeneca Pharmaceuticals LP | $40.99 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116865280 | Medtronic, Inc. | $41.42 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1122118935 | Abbott Laboratories | $161.91 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1138835884 | Edwards Lifesciences Corporation | $11.75 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1138835888 | Edwards Lifesciences Corporation | $182.56 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142291373 | ABIOMED | $31.45 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152975200 | ShockWave Medical, Inc | $103.27 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.